Български
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

oxLDL in Diabetes Mellitus Patients and Disease Periodontal

Само регистрирани потребители могат да превеждат статии
Вход / Регистрация
Линкът е запазен в клипборда
СъстояниеЗавършен
Спонсори
Universidade Estadual Paulista Júlio de Mesquita Filho
Сътрудници
LabviVale

Ключови думи

Резюме

Periodontal disease (PD) and diabetes mellitus type 2 (DM2) have the same inflammatory etiopathogenesis and demonstrate a bidirectional relationship, for DM2 affects the severity of PD, and this may contribute to the overall inflammatory burden of the individual, influencing the natural course DM2. The aim of this study is to establish whether individuals with DM with or without chronic periodontitis have an increase in oxLDL and what is the influence of periodontal treatment in the reduction of oxLDL with consequent improvement in Diabetes Mellitus parameters.

Описание

Periodontal disease (PD) and diabetes mellitus type 2 (DM2) have the same inflammatory etiopathogenesis and demonstrate a bidirectional relationship, for DM2 affects the severity of PD, and this may contribute to the overall inflammatory burden of the individual, influencing the natural course DM2. The aim of this study is to establish whether individuals with DM with or without chronic periodontitis have an increase in oxLDL and what is the influence of periodontal treatment in the reduction of oxLDL with consequent improvement in Diabetes Mellitus parameters. 44 patients will be divided into 2 groups: Diabetic Patients with Chronic Periodontitis (DM2DP) and Diabetic Patients without Chronic Periodontitis (DM2). The DM2DP group will receive periodontal debridement and DM2 group will be treated with supragingival scaling. Both groups receive board control every 3 months. At baseline, 3 and 6 months after treatment, will be held making the clinical periodontal parameters (plaque index, gingival index, probing depth, gingival recession relative clinical attachment level and Periodontal Inflamed Surface Area (PISA) index) and blood collection for assessment serum inflammatory markers (oxLDL, LDL, HDL, total cholesterol, triglyceride, Interleukin (IL) IL-6, IL-8, IL-10, Tumor Necrosis Factor (TNF-α) and CRP). Biochemical analyzes will be carried out by Z-scan technique. The data obtained before and after periodontal therapy will be analyzed using the Shapiro-Wilk test.

Дати

Последна проверка: 10/31/2018
Първо изпратено: 02/05/2017
Очаквано записване подадено: 06/21/2017
Първо публикувано: 06/25/2017
Изпратена последна актуализация: 11/10/2018
Последна актуализация публикувана: 11/13/2018
Действителна начална дата на проучването: 05/01/2016
Приблизителна дата на първично завършване: 08/25/2016
Очаквана дата на завършване на проучването: 01/27/2017

Състояние или заболяване

Type 2 Diabetes Mellitus With Periodontal Disease

Интервенция / лечение

Procedure: Type 2 diabetes mellitus and periodontitis

Фаза

-

Групи за ръце

ArmИнтервенция / лечение
Sham Comparator: Type 2 diabetes mellitus and periodontitis
periodontal debridement in a single session.
Procedure: Type 2 diabetes mellitus and periodontitis
Debridement in a single session in which patients will be anesthetized and receive scaling and root planing with ultrasound equipment .
No Intervention: Type 2 diabetes mellitus and without periodontitis
maintained every three months.

Критерии за допустимост

Възрасти, отговарящи на условията за проучване 35 Years Да се 35 Years
Полове, допустими за проучванеAll
Приема здрави доброволциДа
Критерии

Inclusion Criteria:

- individuals older than 35 years with DM2 diagnosed for more than five years and HbA1c between 7% and 11%;

- be diagnosed with generalized chronic periodontitis: present at least 6 sites with periodontal pocket and loss of insertion above 5mm and two more bags with loss of insertion above 6mm;

- present at least 20 teeth;

- agree to participate in the study and sign the informed consent form

Exclusion Criteria:

- patients with cardiovascular diseases, cancer, gastrointestinal disorders, skin diseases, pregnancy, lactation, smoking, arthritis, lupus or other diseases of inflammatory origin;

- have undergone periodontal treatment in the last 12 months;

- have made use of antioxidant supplements, anti-inflammatories, or antibiotics within the previous 3 months;

- make use of medications that can alter the marking and concentration of oxLDL, for example, statins;

- have changed the medication for glycemic control in the last 3 months;

- present dental elements with pulpal or periapical inflammation.

Резултат

Първични изходни мерки

1. Probing depth change [baseline, 90 and 180 days]

The change in the probing depth will be measure in millimeters before and after the treatment.

Вторични изходни мерки

1. oxLDL concentration Change [baseline and 180 days]

Change in concentration of oxLDL will be measured before and treatment.

2. LDL, HDL, Total cholesterol, Triacylglycerol [baseline and 180 days]

Blood concentration (g/ml) will be measured before and after periodontal therapy.

3. Plaque index [baseline, 90 and 180 days]

Number of teeth affected before and after periodontal treatment

4. Gingival index [baseline, 90 and 180 days]

number of teeth affected before and after periodontal treatment

5. Gingival Recession [baseline, 90 and 180 days]

Evaluated in millimeters before and after the treatment.

6. Clinical Attachment Level [baseline, 90 and 180 days]

Evaluated in millimeters before and after the treatment.

Присъединете се към нашата
страница във facebook

Най-пълната база данни за лечебни билки, подкрепена от науката

  • Работи на 55 езика
  • Билкови лекове, подкрепени от науката
  • Разпознаване на билки по изображение
  • Интерактивна GPS карта - маркирайте билките на място (очаквайте скоро)
  • Прочетете научни публикации, свързани с вашето търсене
  • Търсете лечебни билки по техните ефекти
  • Организирайте вашите интереси и бъдете в крак с научните статии, клиничните изследвания и патентите

Въведете симптом или болест и прочетете за билките, които биха могли да помогнат, напишете билка и вижте болестите и симптомите, срещу които се използва.
* Цялата информация се базира на публикувани научни изследвания

Google Play badgeApp Store badge